3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
2
Solid Tumors
2
Ovarian Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Advanced Malignant Solid Neoplasm
2
Vaginal Neoplasms
1
Triple-negative Metastatic Breast Cancer
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rhabdomyosarcoma
1
Previously Treated Non Small Cell Lung Cancer
1
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
1
Pinealoma
1
Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myelodysplastic-Myeloproliferative Diseases
1
Metastatic Pancreatic Adenocarcinoma
1
Meningeal Carcinomatosis
1
Medulloblastoma
1
Lymphoid Interstitial Pneumonia
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Interventions
Temozolomide
47
Bevacizumab
41
Radiotherapy
17
Magnetic Resonance Spectroscopy
14
Irinotecan
11
Nivolumab
8
Everolimus
7
Radiation
6
poly ICLC
5
X-Rays
5
Phantoms, Imaging
5
Carboplatin
5
pembrolizumab
4
fluorodopa F 18
4
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Erlotinib Hydrochloride
4
Carmustine
4
ribociclib
3
palbociclib
3
ivosidenib
3
antineoplaston A10
3
Vorinostat
3
Radiotherapy, Intensity-Modulated
3
Radiosurgery
3
Modafinil
3
Lomustine
3
Biopsy
3
veliparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Glioma
×
adavosertib
×
Clear all
No trials found.